OptiNose Inc - ESG Rating & Company Profile powered by AI
If you are employed by OptiNose Inc and you wish to licence your Sustainability aseessment, please get in touch. Other companies in the rating industry group for OptiNose Inc are shownin the table. The SDG assessment for OptiNose Inc represents its transparency towards the UN SDGs.
OptiNose Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.9; made up of an environmental score of 0.0, social score of 1.6 and governance score of 4.0.
1.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1608 | Agios Pharmaceuticals Inc | 2.0 | Medium |
| 1608 | Unrivaled Brands Inc | 2.0 | Medium |
| ... | ... | ... | |
| 1617 | OptiNose Inc | 1.9 | Low |
| 1617 | Celsion Corp | 1.9 | Low |
| 1617 | Ainos Inc | 1.9 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does OptiNose Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes OptiNose Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes OptiNose Inc report the average age of the workforce?
Sign up for free to unlockDoes OptiNose Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes OptiNose Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes OptiNose Inc disclose cybersecurity risks?
Sign up for free to unlockDoes OptiNose Inc offer flexible work?
Sign up for free to unlockDoes OptiNose Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes OptiNose Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes OptiNose Inc conduct supply chain audits?
Sign up for free to unlockDoes OptiNose Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes OptiNose Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes OptiNose Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes OptiNose Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes OptiNose Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes OptiNose Inc disclose water use targets?
Sign up for free to unlockDoes OptiNose Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid OptiNose Inc have a product recall in the last two years?
Sign up for free to unlockDoes OptiNose Inc disclose incidents of discrimination?
Sign up for free to unlockDoes OptiNose Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas OptiNose Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes OptiNose Inc disclose parental leave metrics?
Sign up for free to unlockDoes OptiNose Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes OptiNose Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes OptiNose Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes OptiNose Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes OptiNose Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes OptiNose Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs OptiNose Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes OptiNose Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes OptiNose Inc disclose its waste policy?
Sign up for free to unlockDoes OptiNose Inc report according to TCFD requirements?
Sign up for free to unlockDoes OptiNose Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes OptiNose Inc disclose energy use targets?
Sign up for free to unlockDoes OptiNose Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes OptiNose Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for OptiNose Inc
These potential risks are based on the size, segment and geographies of the company.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.